By A Midwestern Doctor - November 7, 2025

Story at-a-glance . . .

• Due to Alzheimer’s research focusing on a symptom of it (amyloid plaques), rather than its actual cause, Alzheimer’s has remained “incurable” for decades.
• Rather than being a single disease, Alzheimer’s has multiple different subtypes (e.g., those due to insulin resistance, nutritional deficiencies, inflammation, infections, or concussions), each of which requires a different treatment.
• Impaired blood circulation to the brain and lymphatic drainage from the brain are often the primary trigger that initiates the degenerative process seen in Alzheimer’s disease.
• Factors which impair this circulation (e.g., poor sleep) hence roughly double the risk of dementia, while treatments which improve this circulation frequently produce remarkable improvements for cognitive decline and dementia.
• DMSO is an effective treatment for brain injuries like strokes, and well-suited to address many of the root causes of dementia and reverse the degenerative state that dying neurons get trapped in. Because of this, there are many reports of it reversing dementia and clinical trials in both humans and animals corroborating these improvements.

This article will review the actual causes of dementias like Alzheimer’s and the forgotten therapies many have successfully used to cure them.

Alzheimer’s dementia is one of the most significant medical challenges our country faces (e.g., it places an incredible burden upon society, e.g., last year it was estimated to cost the United States 360 billion dollars).1 Yet, despite spending billions for research each year, cures remain elusive, something many believe results from the flawed belief that eliminating the amyloid plaques associated with Alzheimer’s will fix it. In turn, as I showed here:

• Decades of amyloid therapies have never produced a beneficial treatment.
• The newest “breakthrough” amyloid-eliminating monoclonal antibodies, at best slightly slow the progression of Alzheimer’s while simultaneously causing a host of side effects, including brain bleeding and swelling in over a quarter of recipients.
• The entire amyloid industry rests upon a fraudulent study no one wanted to retract due to how much was invested in the amyloid hypothesis.

In short . . .

[SNIP]